Neil R. Powe
University of California, San Francisco
575 Papers
3.9K Citations
Neil R. Powe is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Kidney disease. The author has an hindex of 114, co-authored 549 publications. Previous affiliations of Neil R. Powe include Memorial Hospital of South Bend & Brigham and Women's Hospital.
Chat about Author
Papers
Race and kidney function: The facts and fix amidst the fuss, fuzziness, and fiction.
TL;DR: The use of race in clinical algorithms to assess kidney function spurred a passionate and intense debate as discussed by the authors , and the facts, fuss, fuzziness and fiction is key to fixing the problem.
11
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M. Charytan,Jie Yu,Meg Jardine,Christopher P. Cannon,Rajiv Agarwal,George L. Bakris,Tom Greene,Adeera Levin,Carol A. Pollock,Neil R. Powe,Clare Arnott,Kenneth W. Mahaffey +11 more
TL;DR: In CREDENCE, eGFR recalculation without the race-specific coefficient had small but potentially important effects on event rates and the relative proportion of Black participants, without substantially changing efficacy estimates.
11
Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults.
Naomi Anker,Rebecca Scherzer,Carmen A. Peralta,Neil R. Powe,Tanushree Banjeree,Michael G. Shlipak +5 more
TL;DR: It is suggested that clinicians may want to consider estimating glomerular filtration rate without the race coefficient in Blacks with HIV, and racial differences were substantially attenuated when eGFR was re-calculated without theRace coefficient.
11
Early Adoption of Cyclosporine and Recombinant Human Erythropoietin: Clinical, Economic, and Policy Issues With Emergence of High-Cost Drugs
Neil R. Powe,Paul W. Eggers,Paul W. Eggers,Paul W. Eggers,Calvin B. Johnson,Calvin B. Johnson,Calvin B. Johnson +6 more
TL;DR: Two high-cost drugs, cyclosporine and recombinant human erythropoietin (rHuEPO), introduced into the clinical management of patients with kidney disease during the past decade provide some experience concerning the forces affecting the use of expensive drugs in a cost-conscious health care system.
10
Extent and determinants of physician participation in expert witness testimony.
TL;DR: Physician participation in legal review and expert witness activities is significant and appears not to be determined by economic factors, both the positive effects of such participation on the legal system and the potential ethical concerns require further study.
10